A detailed history of Lewis Asset Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Lewis Asset Management, LLC holds 30,395 shares of VKTX stock, worth $1.28 Million. This represents 1.4% of its overall portfolio holdings.

Number of Shares
30,395
Previous 26,445 14.94%
Holding current value
$1.28 Million
Previous $1.4 Billion 37.27%
% of portfolio
1.4%
Previous 1.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$49.84 - $70.47 $196,868 - $278,356
3,950 Added 14.94%
30,395 $1.92 Billion
Q2 2024

Jul 30, 2024

BUY
$47.39 - $80.2 $489,064 - $827,664
10,320 Added 64.0%
26,445 $1.4 Billion
Q1 2024

May 01, 2024

BUY
$17.4 - $94.5 $280,575 - $1.52 Million
16,125 New
16,125 $1.32 Billion

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.24B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Lewis Asset Management, LLC Portfolio

Follow Lewis Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lewis Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lewis Asset Management, LLC with notifications on news.